John Entwistle

Title: Innovations by John Entwistle

Introduction

John Entwistle is an accomplished inventor based in Christiansburg, VA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of fungal infections. With a total of 2 patents, his work has advanced the methodologies used in clinical settings.

Latest Patents

Entwistle's latest patents focus on oligonucleotides that are instrumental in determining the presence of causative agents for human cryptococcosis. These oligonucleotides are derived from a coding segment of the gene encoding the fungal-specific transcription factor gene. They serve as forward and reverse primers for polymerase chain reactions (PCR) using nucleic acids from biological samples. Additionally, they function as probes for detecting resultant amplicons, indicating the presence of the pathogen. His work also includes real-time PCR and detection methods utilizing fluorescence resonance energy transfer.

Career Highlights

John Entwistle is currently associated with Medical Diagnostic Laboratories, LLC, where he applies his expertise in developing diagnostic tools. His innovative approaches have enhanced the accuracy and efficiency of detecting fungal infections, contributing to better patient outcomes.

Collaborations

Entwistle has collaborated with notable colleagues, including Melanie Feola and Martin E Adelson. Their combined efforts have fostered advancements in medical diagnostics and research.

Conclusion

John Entwistle's contributions to the field of medical diagnostics through his patents and collaborations highlight his role as a key innovator. His work continues to impact the detection and treatment of fungal infections, showcasing the importance of innovation in healthcare.